79 related articles for article (PubMed ID: 2788713)
1. Decreased natural killer cell activity in patients with invasive cervical carcinoma.
Chou CY; Hsieh CY; Hsieh KH; Chen CA
Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):128-31. PubMed ID: 2788713
[TBL] [Abstract][Full Text] [Related]
2. Enhanced natural killer cell activity in patients with cervical carcinoma by postoperative PS-K immunotherapy.
Chou CY; Hsieh CY; Chen CA; Hsieh KH
J Formos Med Assoc; 1990 Jun; 89(6):461-5. PubMed ID: 1977861
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up.
Garzetti GG; Ciavattini A; Muzzioli M; Goteri G; Mannello B; Romanini C; Fabris N
Gynecol Obstet Invest; 1995; 40(2):133-8. PubMed ID: 8575692
[TBL] [Abstract][Full Text] [Related]
4. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
5. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
6. Influence of neoadjuvant polychemotherapy on natural killer cell activity in patients with locally advanced cervical squamous carcinoma.
Garzetti GG; Ciavattini A; Provinciali M; Valensise H; Romanini C; Fabris N
Gynecol Oncol; 1994 Jan; 52(1):39-43. PubMed ID: 7508412
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
Brown TE; Bankhurst AD; Strickland RG
J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
[TBL] [Abstract][Full Text] [Related]
8. Subpopulation analysis of human granular lymphocytes: associations with age, gender and cytotoxic activity.
Tilden AB; Grossi CE; Itoh K; Cloud GA; Dougherty PA; Balch CM
Nat Immun Cell Growth Regul; 1986; 5(2):90-9. PubMed ID: 3724768
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III.
Fontana L; Sirianni MC; de Sanctis G; Carbonari M; Ensoli B; Aiuti F
Immunobiology; 1986 Jul; 171(4-5):425-35. PubMed ID: 3017846
[TBL] [Abstract][Full Text] [Related]
10. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
Tilden AB; Itoh K; Balch CM
J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte subpopulations and natural killer activity in endometriosis.
Iwasaki K; Makino T; Maruyama T; Matsubayashi H; Nozawa S; Yokokura T
Int J Fertil Menopausal Stud; 1993; 38(4):229-34. PubMed ID: 8401682
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
13. Spermine-directed immunosuppression of cervical carcinoma cell sensitivity to a majority of lymphokine-activated killer lymphocyte cytotoxicity.
Evans CH; Lee TS; Flugelman AA
Nat Immun; 1995; 14(3):157-63. PubMed ID: 8832899
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity in patients with invasive carcinoma of the cervix.
Park TK; Kim SN
Yonsei Med J; 1989; 30(2):164-72. PubMed ID: 2800566
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of serum T-lymphocyte subsets and NK cell activity in patients with squamous cell carcinoma of pharynx and larynx].
Chen W; Wang X; Tao R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 25(24):1105-7. PubMed ID: 22390028
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
17. Increased natural killer cell activity in uterine cervix cancer patients undergoing radiation therapy.
Pinel MI; Esteves EB; Rumjanek VM
Nat Immun; 1995 Apr; 14(4):216-24. PubMed ID: 8696011
[TBL] [Abstract][Full Text] [Related]
18. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
20. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
Lanier LL; Benike CJ; Phillips JH; Engleman EG
J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
